165 related articles for article (PubMed ID: 30089817)
1. Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells.
Toshiyama R; Konno M; Eguchi H; Takemoto H; Noda T; Asai A; Koseki J; Haraguchi N; Ueda Y; Matsushita K; Asukai K; Ohashi T; Iwagami Y; Yamada D; Sakai D; Asaoka T; Kudo T; Kawamoto K; Gotoh K; Kobayashi S; Satoh T; Doki Y; Nishiyama N; Mori M; Ishii H
Oncogene; 2019 Jan; 38(2):244-260. PubMed ID: 30089817
[TBL] [Abstract][Full Text] [Related]
2. A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma.
Yamashita M; Wada H; Eguchi H; Ogawa H; Yamada D; Noda T; Asaoka T; Kawamoto K; Gotoh K; Umeshita K; Doki Y; Mori M
Int J Oncol; 2016 Jul; 49(1):89-98. PubMed ID: 27121124
[TBL] [Abstract][Full Text] [Related]
3. Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
Tsukamoto H; Shibata K; Kajiyama H; Terauchi M; Nawa A; Kikkawa F
BMC Cancer; 2008 Mar; 8():74. PubMed ID: 18366676
[TBL] [Abstract][Full Text] [Related]
4. Aminopeptidase N inhibitor 4cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibition.
Sun ZP; Zhang J; Shi LH; Zhang XR; Duan Y; Xu WF; Dai G; Wang XJ
Biomed Pharmacother; 2015 Dec; 76():65-72. PubMed ID: 26653552
[TBL] [Abstract][Full Text] [Related]
5. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.
Gao JJ; Gao ZH; Zhao CR; Yuan Y; Cui SX; Zhang XF; Cheng YN; Xu WF; Tang W; Qu XJ
Invest New Drugs; 2011 Aug; 29(4):574-82. PubMed ID: 20111888
[TBL] [Abstract][Full Text] [Related]
6. Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
Wang X; Niu Z; Jia Y; Cui M; Han L; Zhang Y; Liu Z; Bi D; Liu S
Oncol Rep; 2016 Apr; 35(4):2121-30. PubMed ID: 26846372
[TBL] [Abstract][Full Text] [Related]
7. Ubenimex, an APN inhibitor, could serve as an anti‑tumor drug in RT112 and 5637 cells by operating in an Akt‑associated manner.
Wang X; Liu Y; Liu W; Zhang Y; Guo F; Zhang L; Cui M; Liu S; Wu R
Mol Med Rep; 2018 Mar; 17(3):4531-4539. PubMed ID: 29328441
[TBL] [Abstract][Full Text] [Related]
8. BC-02 eradicates liver cancer stem cells by upregulating the ROS-dependent DNA damage.
Dou C; Fang C; Zhao Y; Fu X; Zhang Y; Zhu D; Wu H; Liu H; Zhang J; Xu W; Liu Z; Wang H; Li D; Wang X
Int J Oncol; 2017 Dec; 51(6):1775-1784. PubMed ID: 29039459
[TBL] [Abstract][Full Text] [Related]
9. Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis.
Guo Q; Jing FJ; Xu W; Li X; Li X; Sun JL; Xing XM; Zhou CK; Jing FB
Aging (Albany NY); 2019 Dec; 12(1):80-105. PubMed ID: 31895687
[TBL] [Abstract][Full Text] [Related]
10. Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo.
Yamashita M; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
Int J Cancer; 2007 May; 120(10):2243-50. PubMed ID: 17266036
[TBL] [Abstract][Full Text] [Related]
11. Effect of ubenimex (Bestatin) on the cell growth and phenotype of HL-60 and HL-60R cell lines: up-and down-regulation of CD13/aminopeptidase N.
Imamura N; Kimura A
Leuk Lymphoma; 2000 May; 37(5-6):663-7. PubMed ID: 11042531
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of hybrid of ubenimex-fluorouracil for hepatocellular carcinoma therapy.
Yue K; Hou X; Jia G; Zhang L; Zhang J; Tan L; Wang X; Zhang Z; Li P; Xu W; Li X; Jiang Y
Bioorg Chem; 2021 Nov; 116():105343. PubMed ID: 34544027
[TBL] [Abstract][Full Text] [Related]
13. CD13 is a therapeutic target in human liver cancer stem cells.
Haraguchi N; Ishii H; Mimori K; Tanaka F; Ohkuma M; Kim HM; Akita H; Takiuchi D; Hatano H; Nagano H; Barnard GF; Doki Y; Mori M
J Clin Invest; 2010 Sep; 120(9):3326-39. PubMed ID: 20697159
[TBL] [Abstract][Full Text] [Related]
14. Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts.
Martin-Padura I; Marighetti P; Agliano A; Colombo F; Larzabal L; Redrado M; Bleau AM; Prior C; Bertolini F; Calvo A
Lab Invest; 2012 Jul; 92(7):952-66. PubMed ID: 22546866
[TBL] [Abstract][Full Text] [Related]
15. Ubenimex inhibits cell proliferation, migration and invasion in renal cell carcinoma: the effect is autophagy-associated.
Liu S; Xie F; Wang H; Liu Z; Liu X; Sun L; Niu Z
Oncol Rep; 2015 Mar; 33(3):1372-80. PubMed ID: 25571917
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of tumor cell invasion and induction of apoptosis by ubenimex].
Zheng YB; Gong JH; Li Y; Zhen YS
Yao Xue Xue Bao; 2012 Dec; 47(12):1593-8. PubMed ID: 23460963
[TBL] [Abstract][Full Text] [Related]
17. Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells.
Mishima Y; Matsumoto-Mishima Y; Terui Y; Katsuyama M; Yamada M; Mori M; Ishizaka Y; Ikeda K; Watanabe J; Mizunuma N; Hayasawa H; Hatake K
J Natl Cancer Inst; 2002 Jul; 94(13):1020-8. PubMed ID: 12096087
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-125a attenuates the chemoresistance against ubenimex in non-small cell lung carcinoma via targeting the aminopeptidase N signaling pathway.
Li C; Zhai W; Wan L; Li J; Huang A; Xing S; Fan K
J Cell Biochem; 2020 Feb; 121(2):1716-1727. PubMed ID: 31595566
[TBL] [Abstract][Full Text] [Related]
19. Discovery of BC-01, a novel mutual prodrug (hybrid drug) of ubenimex and fluorouracil as anticancer agent.
Jiang Y; Li X; Hou J; Huang Y; Jia Y; Zou M; Zhang J; Wang X; Xu W; Zhang Y
Eur J Med Chem; 2016 Oct; 121():649-657. PubMed ID: 27322756
[TBL] [Abstract][Full Text] [Related]
20. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
